可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1] Superke HR, Hecht HS. Metabolic disorders contribute to subclinical coronary atherosclerosis in patients with coronary calcification[J]. Am J Cardiol, 2001,88(3):260-264.
[2]Devaraj S, Xu DY, Jialal I. Creaction protein increases plasminogen activator inhibitor1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis[J]. Circulation, 2003,107(3): 398-404.
[3]Huraux C,Makita T,Kurz S,et al. Superoxide productions risk factors, Endothelium dependent relaxations in human internal mammery arteries[J] . Circulation,1999,99(1):53-59.
[4] Heitzer T, Schliinzig T, Krohn K, et al. Endothelial dysfunction, oxidative stress,and risk of cardiovascular events in patients with coronary artery disease[J]. Circulation, 2001,104(22): 2673-2678.
[5] Tausoulis D, Tentolouris C, Toutouzas P. Larginine and thrombosis[J]. Circulation, 2001,104(25):e159.
[6]Patetsios P, Song M, Shutze WP,et al. Identification of uric and xanthine oxidase in atherosclerotic plaque[J]. Am J Cardiol, 2001,88(2):188-191,A6.